COVID-19

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

Despite the increase in availability, many patients still don’t know whether their physicians offer telehealth.

A recently updated Practice Advisory from the American College of Obstetricians and Gynecologists (ACOG) provides an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

The tool becomes available as Good Neighbor Pharmacy surpasses 1 million doses allocated through its Federal Retail Pharmacy Program partnership to independent pharmacies nationwide.

A new study, which was published in JAMA, investigated the immunogenicity in 103 pregnant and lactating individuals aged 18 to 45 years who received either the Pfizer of Moderna COVID-19 vaccines.

Eligible children and teens should receive COVID-19 vaccination to protect them from COVID-19 infection, as well as to reduce the spread of the virus in the community and to vulnerable people, according to the statement.

“On a national level, it was decided that in spite of the lack of information, breastfeeding women should be vaccinated,” said principal investigator Ilan Youngster, MD, MMSc. “Thus, we decided to conduct a study to examine whether anti-SARS-CoV-2 antibodies are secreted into breastmilk and whether any infant adverse events are described.”

A session held virtually at the American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical and Scientific Meeting, which started on April 30, reviewed updates from its COVID-19 task force as we continue to witness the vaccine rollout.

A panel discussion at the 2021 American College of Obstetrics and Gynecology’s (ACOG) Annual and Scientific Meeting, being held virtually April 30-May 2, offers insight into how the COVID-19 pandemic has changed telehealth in ob/gyn.

Round two of the program will provide $249 million to support physicians by providing reimbursement of services necessary for telehealth.

The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.

Treating COVID-19 in pregnant patients brings extra challenges, risks.

The pandemic has forced us to get more creative in managing patients’ needs, especially when it comes to contraception

The National Institutes of Health (NIH) announced that it will offer grant extensions to eligible grantees affected by COVID-19.

The Centers for Disease Control and Prevention (CDC) has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for coronavirus 2019 disease (COVID-19).

In a briefing this morning, the Infectious Diseases Society of America (IDSA) stressed the continued importance of coronavirus 2019 disease (COVID-19) control measures that have been there from the start.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.

Diverse Voices: COVID-19 and the Health of Women, a virtual speaker series run by the NIH Office of Research on Women’s Health (ORWH), presented compiled research on sex and gender disparities during the COVID-19 pandemic. In addition to identifying issues of concern, the webinar offered actions to improve women’s health despite sex and gender disadvantages.

The World Health Organization (WHO) had previously issued guidance recommending that pregnant women should not receive the Moderna Inc. vaccine unless the individual is at high risk of exposure or having a severe case.

Contemporary OB/GYN’s Editor in Chief, Catherine Y. Spong, MD, recently joined Howard Bauchner, MD, Editor in Chief of the Journal of the American Medical Association (JAMA) and Denise J. Jamieson, MD, MPH for a Q&A session to discuss COVID vaccination in pregnant and breastfeeding women.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which will be held from Jan. 25 to Jan. 30.

The World Health Organization (WHO) had previously issued guidance recommending that pregnant women should not receive the Moderna Inc. vaccine unless the individual is at high risk of exposure or having a severe case.

The pandemic brought telehealth into the mainstream, but will government and private payers make the right moves to make it a standard part of medicine?

This FAQ is a printable reference for ob/gyns. It features information on the COVID-19 vaccines, as well as frequently asked questions and answers for ob/gyns to use when counseling patients.

The recommendations address the role of physicians as vaccinators.

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

U.S. FDA staff have recommended monitoring individuals who get the Pfizer or Moderna vaccine shots for possible cases of Bell’s palsy.

Let us know.

COVID-19 exacerbated the global need for reliable healthcare information, but the unparalleled urgency and shrinking timeline made things difficult for providers.

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.